Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways | |
Liu Li; Lu Huizhi; Wang Binu; Deng Xinxin; Wu Longjun; Yang Liping; Zhang Yingying | |
刊名 | MEDICAL SCIENCE MONITOR
![]() |
2018 | |
卷号 | 24 |
关键词 | Apoptosis Cell Cycle Checkpoints Cell Migration Assays |
ISSN号 | 1643-3750 |
DOI | 10.12659/MSM.910702 |
URL标识 | 查看原文 |
收录类别 | SCIE |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4225296 |
专题 | 武汉大学 |
推荐引用方式 GB/T 7714 | Liu Li,Lu Huizhi,Wang Binu,et al. Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways[J]. MEDICAL SCIENCE MONITOR,2018,24. |
APA | Liu Li.,Lu Huizhi.,Wang Binu.,Deng Xinxin.,Wu Longjun.,...&Zhang Yingying.(2018).Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways.MEDICAL SCIENCE MONITOR,24. |
MLA | Liu Li,et al."Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways".MEDICAL SCIENCE MONITOR 24(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论